Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in metastatic or recurrent head and neck cancer
NCT00033618Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2002
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Started Nov 2002; status: completed.
02
Drugs
ixabepilone
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00033618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033618.